U-500 insulin (Humulin R U-500) is a 5×-concentrated formulation used in patients requiring extremely large daily insulin doses (typically >200 units/day). The same volume of insulin contains five times the activity. The wrong syringe — a routine U-100 — produces a 5× overdose. The FDA-mandated U-500-specific syringe is the only safe way to handle it.
Most insulin sold in the U.S. is U-100 — 100 units of insulin activity per mL of solution. For patients with severe insulin resistance who require very high daily doses (often >200 units/day, sometimes >1000 units/day), U-100 becomes impractical: large injection volumes, frequent injections, and pen cartridges that empty in days.
Humulin R U-500 is a concentrated formulation at 500 units/mL — five times the concentration. The same 0.4 mL injection that delivers 40 units of U-100 delivers 200 units of U-500. Daily volumes drop dramatically, fewer injections, longer cartridge life.
If a patient prescribed "120 units of U-500" picks up a routine U-100 syringe and draws "120 units":
At 600 units of insulin in a single bolus, severe hypoglycemia is essentially certain. Without rapid glucose administration, the outcome is coma, seizure, and (without rescue) death. Multiple fatal cases have been documented.
Following adverse-event reports, FDA required dedicated U-500 administration tools:
| Insulin concentration | Right syringe | Wrong syringe → outcome |
|---|---|---|
| U-100 | U-100 syringe | U-500 syringe → 1/5 dose (underdose, hyperglycemia) |
| U-500 | U-500 syringe | U-100 syringe → 5× dose (overdose, severe hypoglycemia) |
| U-40 (veterinary, some legacy) | U-40 syringe | U-100 syringe → 2/5 dose (underdose) |
For most peptide work, you'll never touch U-500. But three lessons translate:
Yes, in carefully selected patients with severe insulin resistance, often type 2 diabetes with very high daily requirements. Usually under endocrinologist management with explicit dose-conversion charts and dedicated U-500 administration tools.
Pharmacologically possible, but clinically discouraged. The math is doable (divide by 5), but the error rate in real-world use is high. The dedicated U-500 syringe or pen exists precisely to remove the conversion step.
Both are sold only in dedicated pens, not vials. The pens dial in standard "units of insulin activity," so the user never sees the volume conversion. No cross-error possible.
Yes, especially compounded GLP-1 vials, which can vary 5× across pharmacies. The same lesson applies — the syringe scale is volume; the drug determines the mass per volume. See <a href="/blog/compounded-semaglutide-concentration-errors-er-visits/">compounded semaglutide concentration errors</a>.
Peptide Protocol records the concentration of every vial and the syringe scale you use — and refuses to compute a dose if they don't match.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.